AC
Accelerator Corp.
Venture CapitalQuietAccelerator is a biotechnology investment and management company.
4
Investments
1
Exits
$440M
AUM
25.0%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Accelerator Corp..
Investment Thesis & Strategy
Accelerator Corp invests in various stages of biotechnology companies, focusing on the biotech sector.
Investment Activity
Deals per year over the last 4 years
1
20183
20191
20207
2021Portfolio Companies
Selected investments from their portfolio of 4 companies
K
Kyverna Therapeutics
Biotech · Series A, 2021
B
Boundless Bio
Biotech · Series A, 2021
A
Acumen Pharmaceuticals
Biotech · Series A, 2021
A
Alumis
Biotech · Series B, 2021
C
Carmot Therapeutics
Biotech · Series B, 2021
N
Neumora Therapeutics
Biotech · Series A, 2021
G
Generate Biomedicines
Biotech · Series B, 2021
A
ArsenalBio
Biotech · Series A, 2020
S
Sana Biotechnology
Biotech · Series B, 2019
L
Lyell Immunopharma
Biotech · Series B, 2019
T
Tessera Therapeutics
Biotech · Series A, 2019
V
Vaxcyte
Biotech · Series A, 2018
Frequently Asked Questions
Accelerator Corp. focuses on Series A, Series B, Series C+ stage investments.
Related Investors
Madrona Venture Group
Seattle, United States · 359 deals
Vulcan Capital
Seattle, United States · 194 deals
Voyager Capital
Seattle, United States · 152 deals
OVP Venture Partners
Seattle, United States · 115 deals
Washington Research Foundation
Seattle, United States · 54 deals
Second Avenue Partners
Seattle, United States · 43 deals